Skip to main content
SpringerLink
Log in

Atrial Fibrillation Ablation and Heart Failure

  • Invasive Electrophysiology and Pacing (J Singh, Section Editor)
  • Published:
Current Cardiology Reports Aims and scope Submit manuscript

Abstract

Atrial fibrillation (AF) worsens outcome in patients with systolic heart failure and the presence of heart failure (HF) predicts a 5- to 6-fold increase in risk of AF. In addition to loss of atrial systole, AF may contribute to left ventricular (LV) systolic dysfunction due a rapid ventricular rate, irregularity of rhythm and exacerbation of mitral regurgitation due to atrial dilatation. Elimination of atrial fibrillation with catheter ablation can improve ejection fraction and reduce heart failure symptoms and appears superior to AV node ablation and bi-ventricular pacing. AF ablation can restore sinus rhythm in most patients with heart failure. Additional study is warranted to identify which patients will receive maximum benefit from aggressive rhythm control and to determine efficacy in patients with diastolic heart failure.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Lloyd-Jones D, Adams DR, Carnethon M, et al. A Report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009;119:e21–181.

    Article  PubMed  Google Scholar 

  2. Lloyd-Jones DM, Wang TJ, Leip EP, et al. Lifetime risk for development of atrial fibrillation: the framingham heart study. Circulation. 2004;110:1042–6.

    Article  PubMed  Google Scholar 

  3. Lloyd-Jones DR, Adams RJ, Brown TM, et al. Heart disease and stroke statistics–2010 update: a report from the American Heart Association. Circulation. 2010;121:e46–215.

    Article  PubMed  Google Scholar 

  4. Lloyd-Jones DM, Larson MG, Leip EP, et al. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation. 2002;106:3068–72.

    Article  PubMed  Google Scholar 

  5. Miyasaka Y, Barnes ME, Bailey KR, et al. Mortality trends in patients diagnosed with first atrial fibrillation. a 21-year community-based study. J Am Coll Cardiol. 2007;49:986–92.

    Article  PubMed  Google Scholar 

  6. Benjamin EJ, Levy D, Vaziri SM, et al. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. J Am Med Assoc. 1994;271:840–4.

    Article  CAS  Google Scholar 

  7. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med. 1992;327:685–91.

  8. Deedwania PC, Singh BN, Ellenbogen K, et al. Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: observations from the veterans affairs congestive heart failure survival trial of antiarrhythmic therapy (CHF-STAT). Circulation. 1998;98:2574–9.

    Article  PubMed  CAS  Google Scholar 

  9. Pedersen OD, Bagger H, Keller N, et al. Efficacy of Dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish Investigations of Arrhythmia and Mortality ON Dofetilide (DIAMOND) substudy. Circulation. 2001;104:292–6.

    Article  PubMed  CAS  Google Scholar 

  10. MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomised intervention trial in congestive heart failure. Lancet. 1999;353:2001–7.

    Google Scholar 

  11. Carson PE, Johnson GR, Dunkman WB, et al. The influence of atrial fibrillation on prognosis in mild to moderate heart failure: the V-HeFT studies. Circulation. 1993;87(6 Suppl VI):VI102–10.

    PubMed  CAS  Google Scholar 

  12. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med. 1987;316:1429–35.

    Google Scholar 

  13. De Ferrari GM, Klersy C, Ferrero P, et al. Atrial fibrillation in heart failure patients: Prevalence in daily practice and effect on the severity of symptoms. Data from the ALPHA study registry. Eur J Heart Fail. 2007;9:502–9.

    Article  PubMed  Google Scholar 

  14. Shillingford J, Thomas M. Hemodynamic effects of acute myocardial infarction in man. Prog Cardiovasc Dis. 1967;9:571–93.

    Article  PubMed  CAS  Google Scholar 

  15. Kieny JR, Sacrez A, Facello A, et al. Increase in radionuclide left ventricular ejection fraction after cardioversion of chronic atrial fibrillation in idiopathic dilated cardiomyopathy. Eur Heart J. 1992;13:1290–5.

    PubMed  CAS  Google Scholar 

  16. Grogan M, Smith HC, Gersh BJ, et al. Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy. Am J Cardiol. 1992;69:1570–3.

    Article  PubMed  CAS  Google Scholar 

  17. Redfield MM, Kay GN, Jenkins LS, et al. Tachycardia-related cardiomyopathy: a common cause of ventricular dysfunction in patients with atrial fibrillation referred for atrioventricular ablation. Mayo Clin Proc. 2000;75:790–5.

    Article  PubMed  CAS  Google Scholar 

  18. Natale A, Zimerman L, Tomassoni G, et al. Impact on ventricular function and quality of life of transcatheter ablation of the atrioventricular junction in chronic atrial fibrillation with a normal ventricular response. Am J Cardiol. 1996;78:1431–3.

    Article  PubMed  CAS  Google Scholar 

  19. Stulak JM, Dearani JA, Daly RC, et al. Left ventricular dysfunction in atrial fibrillation: restoration of sinus rhythm by the Cox-maze procedure significantly improves systolic function and functional status. Ann Thorac Surg. 2006;82:494–500. discussion 500–1.

    Article  PubMed  Google Scholar 

  20. Rahimtoola SH, Ehsani A, Sinno MZ, et al. Left atrial transport function in myocardial infarction. Importance of its booster pump function. Am J Med. 1975;59:686–94.

    Article  PubMed  CAS  Google Scholar 

  21. Linderer T, Chatterjee K, Parmley WW, et al. Influence of atrial systole on the Frank-Starling relation and the end-diastolic pressure-diameter relation of the left ventricle. Circulation. 1983;67:1045–53.

    Article  PubMed  CAS  Google Scholar 

  22. • Khan MN, Jais P, Cummings J, et al. Pulmonary-vein isolation for atrial fibrillation in patients with heart failure. N Engl J Med. 2008;359:1778–85. One of the first randomized multi center controlled trials for AF ablation in HF patients vs AV node ablation and BiV pacing.

    Article  PubMed  CAS  Google Scholar 

  23. •• Gertz ZM, Raina A, Saghy L, et al. Evidence of atrial functional mitral regurgitation due to atrial fibrillation: reversal with arrhythmia control. J Am Coll Cardiol. 2011;58:1474–81. Shows evidence of functional mitral regurgitation reversal with arrhythmia control.

    Article  PubMed  Google Scholar 

  24. Wyse DG, Waldo AL, DiMarco JP, et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 2002;347:1825–33.

    Article  PubMed  CAS  Google Scholar 

  25. Van Gelder IC, Hagens VE, Bosker HA, et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med. 2002;347:1834–40.

    Article  PubMed  Google Scholar 

  26. Roy D, Talajic M, Nattel S, et al. Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med. 2008;358:2667–77.

    Article  PubMed  CAS  Google Scholar 

  27. •• Wilber DJ, Pappone C, Neuzil P, et al. Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. JAMA. 2010;303:333–40. Randomized controlled trial comparing AF ablation in HF patients with drug therapy showing a benefit with ablation.

    Article  PubMed  CAS  Google Scholar 

  28. • Gentlesk PJ, Sauer WH, Gerstenfeld EP, et al. Reversal of left ventricular dysfunction following ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2007;18:9–14. One of the larger cohort studies at a large volume center showing the efficacay of AF ablation in HF patients.

    Article  PubMed  Google Scholar 

  29. • Hsu LF, Jais P, Sanders P, et al. Catheter ablation for atrial fibrillation in congestive heart failure. N Engl J Med. 2004;351:2373–83. A case control study showing that AF ablation in HF patients is possible and efficacious.

    Article  PubMed  CAS  Google Scholar 

  30. Chen MS, Marrouche NF, Khaykin Y, et al. Pulmonary vein isolation for the treatment of atrial fibrillation in patients with impaired systolic function. J Am Coll Cardiol. 2004;43:1004–9.

    Article  PubMed  Google Scholar 

  31. Efremidis M, Sideris A, Xydonas S, et al. Ablation of atrial fibrillation in patients with heart failure: reversal of atrial and ventricular remodelling. Hellenic J Cardiol. 2008;49:19–25.

    PubMed  Google Scholar 

  32. De Potter T, Berruezo A, Mont L, et al. Left ventricular systolic dysfunction by itself does not influence outcome of atrial fibrillation ablation. Europace. 2010;12:24–9.

    Article  PubMed  Google Scholar 

  33. Choi AD, Hematpour K, Kukin M, et al. Ablation vs medical therapy in the setting of symptomatic atrial fibrillation and left ventricular dysfunction. Congestive Heart Fail. 2010;16:10–4.

    Article  Google Scholar 

  34. Lutomsky BA, Rostock T, Koops A, et al. Catheter ablation of paroxysmal atrial fibrillation improves cardiac function: a prospective study on the impact of atrial fibrillation ablation on left ventricular function assessed by magnetic resonance imaging. Europace. 2008;10:593–9.

    Article  PubMed  Google Scholar 

  35. • MacDonald MR, Connelly DT, Hawkins NM, et al. Radiofrequency ablation for persistent atrial fibrillation in patients with advanced heart failure and severe left ventricular systolic dysfunction: a randomised controlled trial. Heart. 2011;97:740–7. This is a small randomized trial with pesistent AF patients and HF comparing ablation and standard therapy.

    Article  PubMed  Google Scholar 

  36. • Dagres N, Varounis C, Gaspar T, et al. Catheter ablation for atrial fibrillation in patients with left ventricular systolic dysfunction. A systematic review and meta-analysis. J Card Fail. 2011;17:964–70. This meta-analysis summarizes much of the important evidence regarding AF ablation in HF patients.

    Article  PubMed  Google Scholar 

  37. • Marrouche NF, Brachmann J. Catheter ablation versus standard conventional treatment in patients with left ventricular dysfunction and atrial fibrillation (CASTLE-AF) - Study design. PACE. 2009;32:987–94. This is a description of a large multi center trial in looking at AF ablation in HF patients.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported in part by the F. Harlan Bartus Research Fund and Murray and Susan Bloom Research Fund at the University of Pennsylvania.

Disclosure

No potential conflicts of interest relevant to this article were reported.

Author information

Authors and Affiliations

  1. Department of Medicine, Electrophysiology Section, Cardiovascular Division, Hospital of the University of Pennsylvania, 9 Founders Pavilion - Cardiology, 3400 Spruce Street, Philadelphia, PA, 19104, USA

    Jonathan Man & Francis E. Marchlinski

Authors
  1. Jonathan Man
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Francis E. Marchlinski
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Francis E. Marchlinski.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Man, J., Marchlinski, F.E. Atrial Fibrillation Ablation and Heart Failure. Curr Cardiol Rep 14, 571–576 (2012). https://doi.org/10.1007/s11886-012-0301-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11886-012-0301-y

Keywords

Search

Navigation